CHIP (Clonal Hematopoiesis of Indeterminate Potential): Potent and Newly Recognized Contributor to Cardiovascular Risk.
作者信息
Libby Peter, Ebert Benjamin L
机构信息
Brigham and Women's Hospital, Boston, MA (P.L.).
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (B.L.E.).
出版信息
Circulation. 2018 Aug 14;138(7):666-668. doi: 10.1161/CIRCULATIONAHA.118.034392.
Abstract
摘要
相似文献
1
CHIP (Clonal Hematopoiesis of Indeterminate Potential): Potent and Newly Recognized Contributor to Cardiovascular Risk.CHIP（意义未明的克隆性造血）：心血管风险的强大且新发现的促成因素
Circulation. 2018 Aug 14;138(7):666-668. doi: 10.1161/CIRCULATIONAHA.118.034392.
2
Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease.克隆性造血：将衰老与心血管疾病中的炎症联系起来。
Nat Rev Cardiol. 2020 Mar;17(3):137-144. doi: 10.1038/s41569-019-0247-5. Epub 2019 Aug 12.
3
Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.体细胞突变和克隆性造血：年龄相关性心血管疾病的潜在新驱动因素。
Circ Res. 2018 Feb 2;122(3):523-532. doi: 10.1161/CIRCRESAHA.117.312115.
4
Clonal hematopoiesis: Genes and underlying mechanisms in cardiovascular disease development.克隆性造血：心血管疾病发展中的基因和潜在机制。
J Cell Physiol. 2019 Jun;234(6):8396-8401. doi: 10.1002/jcp.27752. Epub 2018 Nov 11.
5
Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.探讨不定潜能克隆性造血、髓系恶性肿瘤与动脉粥样硬化之间的关联。
Methods Mol Biol. 2022;2419:73-88. doi: 10.1007/978-1-0716-1924-7_5.
6
Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.克隆性造血的不确定潜能重塑与年龄相关的心血管疾病：JACC 本周综述专题。
J Am Coll Cardiol. 2019 Jul 30;74(4):578-586. doi: 10.1016/j.jacc.2019.05.045.
7
Clonal hematopoiesis and associated diseases: A review of recent findings.克隆性造血与相关疾病：近期研究进展综述。
Cancer Sci. 2021 Oct;112(10):3962-3971. doi: 10.1111/cas.15094. Epub 2021 Aug 12.
8
Clonal hematopoiesis of indeterminate potential and cardiovascular disease.意义未明的克隆性造血与心血管疾病
Transl Res. 2023 May;255:152-158. doi: 10.1016/j.trsl.2022.08.013. Epub 2022 Sep 5.
9
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.克隆性造血与动脉粥样硬化性心血管疾病风险
N Engl J Med. 2017 Jul 13;377(2):111-121. doi: 10.1056/NEJMoa1701719. Epub 2017 Jun 21.
10
Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.克隆性造血不定潜能 (CHIP)：连接体细胞突变、造血、慢性炎症与心血管疾病。
J Mol Cell Cardiol. 2021 Dec;161:98-105. doi: 10.1016/j.yjmcc.2021.07.004. Epub 2021 Jul 21.
引用本文的文献
1
Molecular diagnostics for the monitoring of the cardiac allograft.用于监测心脏移植的分子诊断技术。
JHLT Open. 2025 Jul 25;10:100354. doi: 10.1016/j.jhlto.2025.100354. eCollection 2025 Nov.
2
Dual Nature of Neutrophil Extracellular Traps (NETs)-From Cancer's Ally to Therapeutic Target.中性粒细胞胞外诱捕网（NETs）的双重性质——从癌症的盟友到治疗靶点
Cells. 2025 Aug 5;14(15):1200. doi: 10.3390/cells14151200.
3
Diagnosis, clinical management, and emerging strategies for coronary artery disease in patients with cancer.癌症患者冠状动脉疾病的诊断、临床管理及新出现的策略
Am Heart J Plus. 2025 Jun 26;56:100568. doi: 10.1016/j.ahjo.2025.100568. eCollection 2025 Aug.
4
Impacts of systemic milieu on cerebrovascular and brain aging: insights from heterochronic parabiosis, blood exchange, and plasma transfer experiments.全身环境对脑血管和脑衰老的影响：来自异时联体共生、血液交换和血浆转移实验的见解
Geroscience. 2025 May 23. doi: 10.1007/s11357-025-01657-y.
5
Clonal hematopoiesis of indeterminate potential (CHIP) in cerebromicrovascular aging: implications for vascular contributions to cognitive impairment and dementia (VCID).脑微血管衰老中的不确定潜能克隆性造血（CHIP）：对血管性认知障碍和痴呆（VCID）的影响
Geroscience. 2025 Apr 11. doi: 10.1007/s11357-025-01654-1.
6
Mutational landscape of atherosclerotic plaques reveals large clonal cell populations.动脉粥样硬化斑块的突变图谱揭示了大量克隆细胞群体。
JCI Insight. 2025 Apr 8;10(10). doi: 10.1172/jci.insight.188281. eCollection 2025 May 22.
7
Clonal Hematopoiesis Is Associated With Adverse Clinical Outcomes and Left Ventricular Remodeling in Aortic Stenosis.克隆性造血与主动脉瓣狭窄的不良临床结局及左心室重塑相关。
JACC Adv. 2025 Jan 8;4(2):101532. doi: 10.1016/j.jacadv.2024.101532. eCollection 2025 Feb.
8
Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches.糖尿病中的动脉粥样硬化：新机制及基于机制的治疗方法。
Nat Rev Cardiol. 2025 Jan 13. doi: 10.1038/s41569-024-01115-w.
9
Haematometabolism rewiring in atherosclerotic cardiovascular disease.动脉粥样硬化性心血管疾病中的血液代谢重塑
Nat Rev Cardiol. 2025 Jun;22(6):414-430. doi: 10.1038/s41569-024-01108-9. Epub 2025 Jan 2.
10
Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis.克隆性造血影响新诊断多发性骨髓瘤患者的虚弱程度：一项回顾性多中心分析。
Sci Rep. 2024 Nov 26;14(1):29394. doi: 10.1038/s41598-024-79748-7.
本文引用的文献
1
Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.中性粒细胞胞外诱捕网形成增加促进骨髓增殖性肿瘤的血栓形成。
Sci Transl Med. 2018 Apr 11;10(436). doi: 10.1126/scitranslmed.aan8292.
2
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.白细胞介素-1β作为动脉粥样硬化治疗靶点：CANTOS研究及其他的生物学基础
J Am Coll Cardiol. 2017 Oct 31;70(18):2278-2289. doi: 10.1016/j.jacc.2017.09.028.
3
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.克隆性造血与动脉粥样硬化性心血管疾病风险
N Engl J Med. 2017 Jul 13;377(2):111-121. doi: 10.1056/NEJMoa1701719. Epub 2017 Jun 21.
4
Age-related clonal hematopoiesis associated with adverse outcomes.与不良预后相关的年龄相关性克隆性造血。
N Engl J Med. 2014 Dec 25;371(26):2488-98. doi: 10.1056/NEJMoa1408617. Epub 2014 Nov 26.
5
Inflammation, atherosclerosis, and ischemic events -- exploring the hidden side of the moon.炎症、动脉粥样硬化与缺血性事件——探索月球的另一面
N Engl J Med. 1997 Apr 3;336(14):1014-6. doi: 10.1056/NEJM199704033361409.
Zotero 插件